Summary A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastases and normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal antibodies and the APAAP technique. We found 13 tumours presenting total HLA-ABC loss, five with selective loss of HLA-A antigens and one with absence of HLA-B antigens. These losses were statistically associated with clinical and pathological parameters, such as T stage, degree of differentiation, scores according to the Jakobsson and Glanz grading systems and degree of leukocytic infiltration. Our results lead us to the following conclusions: (a) HLA class I losses were found in a group of tumours showing greater aggressiveness and worse prognosis; (b) these alterations in expression were not associated with an increased metastatic potential. Thus, the absence of HLA molecules in laryngeal tumours is related to greater local aggressiveness, and the loss of class I antigens seems to constitute an adaptive tumour mechanism to avoid the different anatomical and immunological barriers within the larynx.
MHC antigens (H-2 in mice and HLA in man) are membrane glycoproteins which are involved in different immunological phenomena. Specifically, effective T and B cell activation requires MHC class II compatibility between macrophages and T cells, and effective killing by cytotoxic T cells may require HLA class I compatibility between T cells and target cells (i.e. virus-infected and tumour cells) (Thorsby, 1982; Festenstein & Garrido, 1986) . Class I antigens are composed of a highly polymorphic heavy chain associated non-covalently to P2-microglobulin. MHC class I and II antigens are required for peptide presentation to the immune system, including peptides acting as tumour antigens (Townsend et al., 1985) . Alterations in HLA-ABC expression may be one way used by cancer cells to avoid immune destruction (Garrido, 1987) . Decreased HLA expression has been discovered in several human tumours, including breast, skin, colorectal, gastric and laryngeal carcinomas (L6pez- Nevot et al., 1986 Ruiz-Cabello et al., 1989) . However, few studies have analysed the mechanisms responsible for such alterations. In previous papers we investigated changes in the expression of HLA class I antigens during malignant transformation of the laryngeal epithelium, and some of the mechanisms involved . MHC class II antigens were only found in verrucous cell carcinomas, thus DR expression seem to be associated with tumours with excellent prognosis (Esteban et al., 1990) . The objective of the present work is to analyse further the group of tumours in which such alterations were found, from both clinical and pathological approaches, to evaluate the prognostic significance of MHC class I antigens in patients with laryngeal carcinoma.
Materials and methods

Patients
Sixty patien s with squamous cell carcinoma of the larynx were included in the study. None of them received radiotherapy or chemotherapy prior to surgery. All were male. Age ranged from 44 to 75 years (average 58.68 (Wahi, 1972) ) and all were scored according to Glanz's (1984) and Jakobsson's (Jakobsson et al., 1973) grading systems for squamous cancer. In addition, two modifications to the former were included (Crissman et al. (1984) 
Immunohistochemical analysis
The immunohistochemical technique and monoclonal antibodies used were described in a previous publication (Table I ).
The study of the pathological parameters between groups also yielded differences (Table II) .
Clinical parameters
The clinical parameters significantly associated with the loss of class I antigens are shown in Table III . We excluded tumours of the pyriform sinus from our analysis, as they present a different biological behaviour, and most series consider them separately. The comparison of the mean interval between first symptom and diagnosis also yielded significant differences.
The relationship between HLA-ABC losses (total and selective losses) and metastatic potential is shown in Figure 4 . The P value was 0.1771. In this analysis we excluded both pyriform sinus carcinomas and verrucous carcinomas in order to work with a homogeneous group.
Most class I negative tumours were classified as advanced stages ( Figure 5 ). We found a close relationship between class I expression and staging of the cases, most of the negative class I tumours being stage IV (9 out of 12). As there was no significant association between metastatic potential and class I losses, it seems that HLA class I negative tumours were bigger and grew deeper than those in the positive group. At present, ten patients had died of disease, and six of them had tumours presenting total or selective loss of HLA-ABC antigens.
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Discussion
Because of the central role of class I and II molecules in the (Zinkernagel & Doherty, 1979) . Although our studies do not elucidate the molecular basis of the defect in expression of class I antigens, regulatory mechanisms, rather than genetic rearrangements, are likely to be involved in these phenomena, as shown by the results of the southern blotting analyses in our series . In fact, in many human tumours with undetectable levels of class I antigen expression, HLA expression has been induced by exposing the neoplastic cells to t-interferon (Ruiz-Cabello et al., 1988 . Further evidence supporting the hypothesis that regulatory mechanisms are involved in the control of the expression of MHC products comes from oncogene studies. The amplification of c-myc has been shown to correlate with low levels of class I molecules (Doyle et al., 1985) , and other studies in neuroblastoma (Lamson et al., 1983) and melanoma cell lines (Versteeg et al., 1988) have also found an association between c-myc and N-myc amplification and a decrease in class I molecule expression. These authors claim that repression of the expression may be a common feature in oncogene-mediated malignant transformation.
Our comparative analysis of tumours with total loss of MHC class I antigen expression with tumours showing levels of expression considered normal suggest a number of conclusions. To assess the malignancy of these tumours, because of the short follow-up period (12-48 months), we used the criteria of Jakobsson et al. (1973) with two modifications (Crissman et al. (1984) and our own modification) and criteria established by Glanz (1984) . As described in Table II (Table II) . The strong association with vascular invasion was somewhat amazing, as tumours with altered class I expression have not been significantly associated with the presence of metastases (Figure 4) . We should however point out that vascular invasion itself has been linked with an ominous prognosis (Poleksic & Kalwaic, 1978) . Tumour cell lysis mediated by NK cells could be an explanation of this finding. Another apparent discrepancy was that tumours with altered class I expression were not significantly associated with advanced stages of histopathological invasion (Table II) , whereas the association was evident with advanced clinicopathological invasion (P = 0.0001; Table III ). This may be derived from the grading systems used, as most tumours were classified as showing 'deep infiltration', whereas they differed clearly enough to be categorised as T3 or T4 when studying the surgical specimens.
On the other hand, we have observed that the loss of class I antigens is strongly associated with the degree of differentiation (Figure 3 ), a phenomenon also noted in other carcinomas, i.e. colon carcinomas (Momburg et al., 1986) . There was a clear relationship between loss of class I antigens and the different grading systems of malignancy employed, as described in Table I . When analysing the different parameters which ar,e considered to reflect the differentiation of the tumour cell, the strongest association for class I tumours was found with the parameter that we called 'overall cellular differentiation; (P = 0.0011). A less marked but still high significant association was noted for cytoplasmic differentiation (keratin formation) (Table II) .
There was a strong relationship between the absence or selective loss of class I molecules and the T stage (TNM classification), but not with maximum diameter of the neoplasm, suggesting that the main factor was degree of deep invasion of the tumour rather than superficial spreading. This phenomenon has also been observed in malignant melanoma (Brocker et al., 1985) and may be explained in terms of 'tumour' progression', i.e. the natural history of spontaneous tumours being a multistep process in which new clones replace their precursors as a result of selection (Cairns, 1975; Klein & Klein, 1985) . The loss of class I antigen expression associated with advanced T stages may result from phenotypical changes which benefit the neoplastic cell growth. In this way, the classical studies of the different anatomical and biochemical laryngeal barriers are of significance (Tucker, 1976; Kirchner & Carter, 1987) . Moreover, in contrast to the large number of studies relating the degree of differentiation to metastatic potential (see for review in Glanz, 1984) , only a limited number of publications have linked larger tumours with higher rates of metastasis (McGavran et al., 1961; Kirchner et al., 1974; Pera et al., 1986) . The analysis of tumours using the different grading systems of malignancy seems to point toward a gradient from positive tumours with lower scores and better prognosis, to HLA-ABC negative tumours, being a intermediate group the neoplasms with selective losses of HLA-A or HLA-B antigens (data not shown). It is interesting to remark the other clinicopathological parameters associated with alterations in class I expression. Duration of symptoms is an indirect measure of tumour aggressiveness, or at least of the rate of neoplastic growth. Notably, class I negative tumours also exhibited a short first symptom-diagnosis interval (Table III) with a significant difference between negative (mean 4.5 months) and positive tumours (mean 15.7 months, P = 0.0091). Thus, class I negative tumours seem to show a highly aggressive histopathological profile, as shown by the significance found in all the grading systems used, as well as on the basis of clinical criteria, i.e. association with advanced T stage and short first symptom-diagnosis interval, and worse prognosis as reflected by the patient's status.
In conclusion, the association between loss of HLA-ABC expression and a number of parameters related to tumour aggressiveness supports the hypothesis that the study of class I expression in laryngeal cancer may be considered of clinical value. A negative result for class I antigen expression may indicate deep infiltration by the tumour, which could be difficult to detect before surgery has been performed. Further investigations will be needed to ascertain the role of HLA antigens in the immunobiology of laryngeal squamous cell carcinoma, being follow-up studies necessary to evaluate the prognostic significance of the alterations in class I antigen expression.
